Page last updated: 2024-10-30

3-phenyllactic acid and Mucormycosis

3-phenyllactic acid has been researched along with Mucormycosis in 1 studies

3-phenyllactic acid: alpha-hydroxy analog of phenylalanine; RN given refers to cpd without isomeric designation
3-phenyllactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.

Mucormycosis: Infection in humans and animals caused by any fungus in the order MUCORALES (e.g., RHIZOPUS; MUCOR; CUNNINGHAMELLA; APOPHYSOMYCES; ABSIDIA; SAKSENAEA and RHIZOMUCOR) There are many clinical types associated with infection including central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an OPPORTUNISTIC INFECTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lunavath, R1
Mohammad, SH1
Bhukya, KK1
Barigela, A1
Banoth, C1
Banothu, AK1
Bhukya, B1

Other Studies

1 other study available for 3-phenyllactic acid and Mucormycosis

ArticleYear
Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated mucormycosis causing fungi.
    PloS one, 2023, Volume: 18, Issue:3

    Topics: Animals; Anti-Infective Agents; Bees; COVID-19; Fungi; Humans; Lactobacillales; Mucormycosis; Polyes

2023